Monitor the Nasdaq Hearings Panel decision timeline and any compliance plan details. If the panel denies the extension or the company fails to regain compliance within the granted period, delisting and a move to OTC markets would likely occur, further pressuring the stock.
Price Chart
Executive Summary
Kyntra Bio received a delisting determination from Nasdaq on September 30, 2026, for failing to comply with Listing Rule 5450(b) (requiring $50M each in total assets and total revenue). The company has requested a hearing to stay the delisting and seek up to 180 additional days to regain compliance, but there is no assurance the panel will grant an extension or that compliance can be achieved.
Key Facts
- Nasdaq Staff determined to delist Kyntra Bio's common stock from the Nasdaq Global Select Market for non-compliance with Listing Rule 5450(b).
- The company failed to meet the $50 million minimum total assets and total revenue requirement for the most recently completed fiscal year or two of the last three fiscal years.
- Kyntra Bio also did not satisfy alternative stockholders' equity or market value of listed securities standards under Rule 5450(b).
- A timely hearing request has been filed to stay the delisting pending the Panel's decision; an extension of up to 180 days from the determination date is possible.
- Trading under symbol KYNB continues on Nasdaq pending the Panel's written decision.
Financial Impact
Delisting would severely reduce liquidity and institutional ownership; no specific dollar amounts provided in the filing.
Risk Factors
- Panel may deny the hearing request or grant insufficient time to regain compliance.
- Company may be unable to meet the $50M asset/revenue threshold or alternative standards within any extension period.
- Delisting would trigger a loss of institutional eligibility and reduced trading liquidity.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-415545 |
| Document: 0001193125-26-415545-index-headers.html | 0001193125-26-415545 |
| Document: 0001193125-26-415545-index.html | 0001193125-26-415545 |
| Document: 0001193125-26-415545.txt | 0001193125-26-415545 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 6, 2026 21d ago | 3 | $6.13 $5.57 | ▼ −9.22% | ▼ −8.24% | $4.50 (−26.59%) |
Oct 6, 2026 21d ago | 8-K | $6.13 $5.57 | ▲ +9.22% | ▲ +8.24% | $4.50 (+26.59%) |
Oct 1, 2026 26d ago | 8-K | $6.50 $5.96 | ▼ −8.31% | ▼ −9.61% | $4.50 (−30.77%) |
Jun 9, 2026 20w ago | 8-K | $6.69 $6.91 | ▲ +3.29% | ▼ −0.14% | $4.50 (−32.74%) |
May 11, 2026 24w ago | Press Release | $7.23 $6.83 | ▼ −5.47% | ▼ −5.54% | $4.50 (−37.72%) |
Mar 16, 2026 32w ago | Press Release | $7.37 $6.75 | ▲ +8.41% | ▲ +5.76% | $4.50 (+38.94%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers